Francisco Silva
Vice President of Research and Development
Replay available
BioRestorative Therapies, Inc. (NASDAQ: BRTX) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

Vice President of Research and Development
Investor Relations
Chairman and Chief Executive Officer
Analyst, Ross Capital Partners
Analyst, Maxim
Chief Financial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Biorestorative Therapies, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.416 Welcome to the Bio-Restorative Therapies Second Quarter 2025 00:00:05.416 -- 00:00:08.939 Results and Business Update Conference Call. 00:00:08.939 -- 00:00:12.742 At this time, all participants are in a listen-only mode. 00:00:12.742 -- 00:00:16.866 A question and answer session will follow the formal presentation. 00:00:16.866 -- 00:00:21.650 If anyone should require operator assistance during the conference, please press star 00:00:21.650 -- 00:00:26.995 zero on your telephone keypad. Please note this conference is being recorded. 00:00:26.995 -- 00:00:31.949 I will now turn the conference over to your host, Stephen Kilmer, Investor Relations. 00:00:31.949 -- 00:00:34.309 You may begin. 00:00:34.975 -- 00:00:39.904 Thank you, Ali. Good afternoon, everyone. Let me start by pointing out that this conference 00:00:39.904 -- 00:00:43.731 call will include forward-looking statements within the meaning of the Private Securities 00:00:43.731 -- 00:00:47.338 Litigation Reform Act of 1995. All 00:00:47.338 -- 00:00:51.486 forward-looking statements are based on biorestorative therapy's current beliefs, assumptions, 00:00:51.486 -- 00:00:53.153 and expectations. 00:00:53.153 -- 00:00:56.898 And such statements involve known and unknown risks, uncertainties, and other factors 00:00:56.898 -- 00:01:00.803 that may cause actual results, performance, or achievements to be materially different 00:01:00.803 -- 00:01:06.130 from those implied by such statements. No forward-looking statement can be guaranteed. 00:01:06.130 -- 00:01:10.196 For details on factors, among others, that could affect our expectations, 00:01:10.196 -- 00:01:15.303 see Part 1, Item 1A of our annual report on Form 10-K for the year ended December 00:01:15.303 -- 00:01:19.9...